Key facts
- This page summarizes Paul A. Friedman's Form 4 filing for MADRIGAL PHARMACEUTICALS, INC. (MDGL).
- 13 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 18 Jul 2025, 16:13.
Paul A. Friedman - 16 Jul 2025 Form 4 Insider Report for MADRIGAL PHARMACEUTICALS, INC. (MDGL)
- Form type
- 4
- Accepted by SEC
- 18 Jul 2025, 16:13:03 UTC
- Previous filing
- 24 Jun 2025
- Next filing
- 22 Jul 2025
- SEC filing
- View on sec.gov
- Reporting owner signature
- /s/ Mardi Dier, as Attorney-in-Fact
SEC evidence
5 facts
Reporting owner
1 fact
Key filing fact
Paul A. Friedman filed Form 4 for MADRIGAL PHARMACEUTICALS, INC. (MDGL) on 18 Jul 2025.
Change
- Previous filing in this sequence was filed on 24 Jun 2025.
- Current net transaction value: -$9,925,966.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001236927
Primary reporting owner
FRIEDMAN PAUL A
- Relationship
- Director
- Address
- C/O MADRIGAL PHARMACEUTICALS, INC., 200 BARR HARBOR DRIVE, SUITE 400, WEST CONSHOHOCKEN
- Signature
- /s/ Mardi Dier, as Attorney-in-Fact
- Signature date
- 18 Jul 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MDGL
transaction
Common Stock
Options Exercise
- Transaction value
- $247,363
- Shares
- +26,176
- Change %
- +14%
- Price
- $9.45
- Shares after
- 213,340
- Date
- 16 Jul 2025
- Ownership
- Direct
MDGL
transaction
Common Stock
Sale
- Transaction value
- $1,940,275
- Shares
- -5,541
- Change %
- -2.6%
- Price
- $350.17
- Shares after
- 207,799
- Date
- 16 Jul 2025
- Ownership
- Direct
- Footnotes
- F1, F2
MDGL
transaction
Common Stock
Sale
- Transaction value
- $833,131
- Shares
- -2,371
- Change %
- -1.1%
- Price
- $351.38
- Shares after
- 205,428
- Date
- 16 Jul 2025
- Ownership
- Direct
- Footnotes
- F1, F3
MDGL
transaction
Common Stock
Sale
- Transaction value
- $744,133
- Shares
- -2,110
- Change %
- -1%
- Price
- $352.67
- Shares after
- 203,318
- Date
- 16 Jul 2025
- Ownership
- Direct
- Footnotes
- F1, F4
MDGL
transaction
Common Stock
Sale
- Transaction value
- $820,507
- Shares
- -2,319
- Change %
- -1.1%
- Price
- $353.82
- Shares after
- 200,999
- Date
- 16 Jul 2025
- Ownership
- Direct
- Footnotes
- F1, F5
MDGL
transaction
Common Stock
Sale
- Transaction value
- $2,429,697
- Shares
- -6,851
- Change %
- -3.4%
- Price
- $354.65
- Shares after
- 194,148
- Date
- 16 Jul 2025
- Ownership
- Direct
- Footnotes
- F1, F6
MDGL
transaction
Common Stock
Sale
- Transaction value
- $2,056,860
- Shares
- -5,784
- Change %
- -3%
- Price
- $355.61
- Shares after
- 188,364
- Date
- 16 Jul 2025
- Ownership
- Direct
- Footnotes
- F1, F7
MDGL
transaction
Common Stock
Sale
- Transaction value
- $427,941
- Shares
- -1,200
- Change %
- -0.64%
- Price
- $356.62
- Shares after
- 187,164
- Date
- 16 Jul 2025
- Ownership
- Direct
- Footnotes
- F1, F8
MDGL
transaction
Common Stock
Options Exercise
- Transaction value
- $25,515
- Shares
- +2,700
- Change %
- +1.4%
- Price
- $9.45
- Shares after
- 189,864
- Date
- 17 Jul 2025
- Ownership
- Direct
MDGL
transaction
Common Stock
Sale
- Transaction value
- $700,203
- Shares
- -2,000
- Change %
- -1.1%
- Price
- $350.10
- Shares after
- 187,864
- Date
- 17 Jul 2025
- Ownership
- Direct
- Footnotes
- F1, F9
MDGL
transaction
Common Stock
Sale
- Transaction value
- $246,098
- Shares
- -700
- Change %
- -0.37%
- Price
- $351.57
- Shares after
- 187,164
- Date
- 17 Jul 2025
- Ownership
- Direct
- Footnotes
- F1, F10
MDGL
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 655,540
- Date
- 16 Jul 2025
- Ownership
- By SQN LLC
- Footnotes
- F11
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MDGL
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -26,176
- Change %
- -13%
- Price
- $0.000000
- Shares after
- 180,080
- Date
- 16 Jul 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 26,176
- Exercise price
- $9.45
- Footnotes
- F12
MDGL
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -2,700
- Change %
- -1.5%
- Price
- $0.000000
- Shares after
- 177,380
- Date
- 17 Jul 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,700
- Exercise price
- $9.45
- Footnotes
- F12
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 12 footnotes
Footnote F1
These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.
Footnote F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.00 to $350.79, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.
Footnote F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $351.01 to $352.00, inclusive.
Footnote F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $352.09 to $352.98, inclusive.
Footnote F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $353.12 to $354.08, inclusive.
Footnote F6
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $354.13 to $355.12, inclusive.
Footnote F7
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $355.13 to $356.11, inclusive.
Footnote F8
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $356.18 to $357.00, inclusive.
Footnote F9
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.00 to $350.61, inclusive.
Footnote F10
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $351.17 to $352.00, inclusive.
Footnote F11
The Reporting Person and his spouse are each managing members of SQN, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Footnote F12
The shares underlying this stock option are fully vested and exercisable.